01Impact factor
Impact factor of Cancer Epidemiology Biomarkers & Prevention (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Cancer Epidemiology Biomarkers & Prevention published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Public, Environmental & Occupational Healthrank 345 of 443 journals
- Oncologyrank 285 of 347 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Cancer Epidemiology Biomarkers & Prevention
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cancer Epidemiology Biomarkers & Prevention is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Cancer Epidemiology Biomarkers & Prevention?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Public, Environmental & Occupational Health accept papers in a median of 9 days.
- Journal of Community Health 9 days
- Current Epidemiology Reports 38 days
- Progress in Palliative Care 50 days
APC waivers and discounts for Cancer Epidemiology Biomarkers & Prevention
No published waiver policy found for its publisher. Ask the editorial office, and compare publishers that do waive the APC.
02Retractions
Retractions and research integrity at Cancer Epidemiology Biomarkers & Prevention
Most common reasons (a retraction can have several):
Cancer Epidemiology Biomarkers & Prevention has 4 retracted papers on record, the latest in Jun 2021. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
03Funders
Who funds research published in Cancer Epidemiology Biomarkers & Prevention
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Cancer Epidemiology Biomarkers & Prevention
- ISSN
- 1055-9965
- eISSN
- 1538-7755
- Publisher
- American Association for Cancer Research all its journals →
- Subjects
- Oncology, Public, Environmental & Occupational Health
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Cancer Epidemiology Biomarkers & Prevention
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Cancer Epidemiology Biomarkers & Prevention accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Cancer Epidemiology Biomarkers & Prevention is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Cancer Epidemiology Biomarkers & Prevention
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Cancer Epidemiology Biomarkers & Prevention, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Public, Environmental & Occupational Health journals with a similar impact factor*
The journals next to Cancer Epidemiology Biomarkers & Prevention when the 415 journals of Public, Environmental & Occupational Health in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 341 | SAHARA-J Journal of Social Aspects of HIV/AIDS | 1.00 | SSCI | Fully open access |
| 342 | Global Health Promotion | 0.98 | SSCI | Subscription |
| 343 | Revista Brasileira de Epidemiologia | 0.98 | ESCI | Fully open access |
| 344 | Pan African Medical Journal | 0.96 | ESCI | Fully open access |
| 346 | Journal of Men s Health | 0.94 | SCIE, SSCI | Fully open access |
| 347 | The Canadian Journal of Human Sexuality | 0.92 | ESCI | Subscription |
| 348 | Journal of the Association of Nurses in AIDS Care | 0.91 | SCIE, SSCI | Subscription |
| 349 | Western Pacific surveillance response journal | 0.91 | ESCI | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Cancer Epidemiology Biomarkers & Prevention right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,240 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Cancer Epidemiology Biomarkers & Prevention?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Cancer Epidemiology Biomarkers & Prevention is 0.94: papers it published in the two previous years were cited 0.94 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Cancer Epidemiology Biomarkers & Prevention?
The h-index of Cancer Epidemiology Biomarkers & Prevention is 210 (October 2026): 210 of its papers have each been cited at least 210 times. Its i10-index is 5,633.
What is the quartile of Cancer Epidemiology Biomarkers & Prevention?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cancer Epidemiology Biomarkers & Prevention is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Cancer Epidemiology Biomarkers & Prevention indexed in Scopus?
Yes. Cancer Epidemiology Biomarkers & Prevention appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cancer Epidemiology Biomarkers & Prevention an SCIE journal?
Yes. Cancer Epidemiology Biomarkers & Prevention is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cancer Epidemiology Biomarkers & Prevention in Journal Citation Reports (JCR)?
Yes. Cancer Epidemiology Biomarkers & Prevention is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Has Cancer Epidemiology Biomarkers & Prevention retracted papers?
Yes. 4 retracted papers are on record for Cancer Epidemiology Biomarkers & Prevention, 2 of them in the last 10 years; the most common reasons are error in analyses, error in results and/or conclusions, error in methods. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Cancer Epidemiology Biomarkers & Prevention?
2% of 200 recent research articles in Cancer Epidemiology Biomarkers & Prevention name a funder; the funders named most often are National Cancer Institute, Wereld Kanker Onderzoek Fonds, World Cancer Research Fund International.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Astronomy and Astrophysics
- Construction and Building Materials
- Investigative Ophthalmology and Visual Science
- Materials
- European journal of cancer
- Transplantation
- Heliyon
- Applied Physics Letters
- Journal of Physical Chemistry A
- Neurology
- Alzheimer's and Dementia
- Frontiers in Immunology
- Cancer Research
- Journal of Agricultural and Food Chemistry
Browse all journals: indexing, impact factor and reviewer comments →